Picture of Amicus Therapeutics logo

FOLD — Amicus Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Amicus Therapeutics Q3 Revenue USD 141.5 Million Vs. IBES Estimate USD 135.3 Million

Nov 06 (Reuters) - Amicus Therapeutics Q3 net income USD -6.7 million.
* Q3 EPS USD -0.02
* Q3 adjusted operating expenses USD 82.6 million
* Q3 operating expenses USD 106.6 million

Recent news on Amicus Therapeutics

See all news